Utility and reproducibility of semiquantitative analysis of sestamibi breast images

Journal of Nuclear Medicine Technology

Volumn 25, Issue 2, 1997, Pages 106-109

  Dunnwald, L K ^a   Hartnett, S D ^a   Mankoff, D A ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Breast imaging; Regions of interest; Semiquantitative ratios; Technetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BREAST CANCER; BREAST TUMOR; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAMMOGRAPHY; REPRODUCIBILITY; THORAX WALL;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; HUMANS; IMAGE ENHANCEMENT; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; OBSERVER VARIATION; PRONE POSITION; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THORAX;

EID: 0030993229     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Palmedo H, Schomburg A, Grunwald F, et al. Technetium-99m-sestamibi scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-630.
2. Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with suspicion of carcinoma of the breast. J Am Coll Surg 1994;178:491-497.
3. 99mTc-sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
4. Khalkhali I, Mena I, Diggles L. Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m-sestamibi. Eur J Nucl Med 1994;21:357-362.
5. Taillefer R, Robidoux A, Lambert R, et al. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
6. Kao CH, Wang SJ, Yeh SH. Technetium-99m-sestamibi uptake in breast carcinoma and axillary lymph node metastases. Clin Nucl Med 1994;19:898-900.
7. Mankoff DA, Gralow JR, Dunnwald LK, et al. Technetium-99m-sestamibi scintimammography to measure the breast cancer response to neo-adjuvant chemotherapy [Abstract]. J Nucl Med 1996;37:252P.
8. Varrella P, Lastoria S, Vergara E, et al. Technetium-99m-sestamibi scintimammography for monitoring tumor response in patients with advanced breast cancer [Abstract]. J Nucl Med 1995;36:193P.
9. Kao CH, Wang SJ, Liu TJ. The use of technetium-99m-methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses. Eur J Nucl Med 1994;21:432-436.
10. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m-sestamibi: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994;21: 984-987.
11. 99mTc-sestamibi:correlation of semi-quantitative indices of uptake with pathology [Abstract]. Clin Nucl Med 1995;20:857.
12. 99mTc-sestamibi uptake correlate with the pathologic features of malignant breast lesions [Abstract]. J Nucl Med 1996;37:267P.
13. Khalkhali I, Cutrone J, Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995;36:1784-1789.
14. Piccolo S, Lastoria S, Mainolfi C, et al. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer. J Nucl Med 1995;36:718-724.
15. Diggles L, Mena I, Khalkhali I, Technical aspects of prone dependent-breast scintimammography. J Nucl Med Technol 1994;22:165-170.
16. Peller PJ, Khedkar NY, Martinez CJ. Breast tumor scintigraphy. J Nucl Med Technol 1996;24:198-203.
17. 99mTc sestamibi in scintimammography: its correlation with the menstrual cycle [Abstract]. J Nucl Med Technol 1994;22:111.